- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Jansen-Olliges, L.; Chatterjee, S.; Jia, L.; Stahl, F.; Bär, C. et al.: Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor. In: Cells 12 (2023), Nr. 1, 83. DOI: https://doi.org/10.3390/cells12010083
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Gottfried Wilhelm Leibniz Universität Hannover
- (wann)
-
2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Technische Informationsbibliothek (TIB)
- (wann)
-
2023
- Urheber
-
Jansen-Olliges, Linda
Chatterjee, Shambhabi
Jia, Lili
Stahl, Frank
Bär, Christian
Stadler, Marc
Surup, Frank
Zeilinger, Carsten
- DOI
-
10.15488/15700
- URN
-
urn:nbn:de:101:1-2023122101311393024620
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jansen-Olliges, Linda
- Chatterjee, Shambhabi
- Jia, Lili
- Stahl, Frank
- Bär, Christian
- Stadler, Marc
- Surup, Frank
- Zeilinger, Carsten
- Gottfried Wilhelm Leibniz Universität Hannover
- Technische Informationsbibliothek (TIB)
Entstanden
- 2023
Ähnliche Objekte (12)
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
ACE2: the molecular doorway to SARS-CoV-2
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
ACE2: the molecular doorway to SARS-CoV-2
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
ACE2: the molecular doorway to SARS-CoV-2
Plastic Antibodies Mimicking the ACE2 Receptor for Selective Binding of SARS‐CoV‐2 Spike
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Smoking increases expression of the SARS-CoV-2 spike protein-binding long ACE2 isoform in bronchial epithelium